TY - JOUR AB - Cancer is the leading cause of death worldwide. The absence of obvious symptoms and insufficiently sensitive biomarkers in early stages of carcinoma limits early diagnosis. Cancer therapy agents and targeted therapy have been used extensively against tissues or organs of specific cancers. However, the intrinsic and/or acquired resistance to the agents or targeted drugs as well as the serious toxic side effects of the drugs would limit their use. Therefore, identifying biomarkers involved in tumorigenesis and progression represents a challenge for cancer diagnosis and therapeutic strategy development. The eukaryotic translation factor 5A (eIF5A), originally identified as an initiation factor, was later shown to promote translation elongation of iterated proline sequences. There are two eIF5A isoforms (eIF5A1 and eIF5A2). eIF5A2 protein consists of 153 residues, and shares 84% amino acid identity with eIF5A1. However, the biological functions of these two isoforms may be significantly different. Recently, it was demonstrated that eIF5Ais widely involved in the pathogenesis of a number of diseases, including cancers. In particular, eIF5A plays an important role in regulating tumor growth, invasion, metastasis and tumor microenvironment. It was also shown to serve as a potential biomarker and target for the diagnosis and treatment of cancers. The present review briefly discusses the latest findings of eIF5A in the pathogenesis of certain malignant cancers and evolving clinical applications. AD - Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China Department of Thyroid Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China AU - Ning,Liang AU - Wang,Lei AU - Zhang,Honglai AU - Jiao,Xuelong AU - Chen,Dong DA - 2020/10/01 DO - 10.3892/ol.2020.11942 IS - 4 JO - Oncol Lett KW - eukaryotic translation initiation factor 5A cancer apoptosis proliferation metastasis PY - 2020 SN - 1792-1074 1792-1082 SP - 81 ST - Eukaryotic translation initiation factor 5A in the pathogenesis of cancers (Review) T2 - Oncology Letters TI - Eukaryotic translation initiation factor 5A in the pathogenesis of cancers (Review) UR - https://doi.org/10.3892/ol.2020.11942 VL - 20 ER -